Clinical Trials Logo

Clinical Trial Summary

Autologous arteriovenous fistula (AVF) is the preferred vascular pathway type for maintenance hemodialysis (MHD) patients. The K/DOQI guidelines suggest that the use of percutaneous transluminal angioplasty (PTA) as the primary treatment for AVF stenosis is reasonable. However, the durability of PTA is limited. In order to reduce the risk of dysfunction recurrence after the intervention, there have been reports in recent years that drug-coated balloons (DCB) are used in the treatment of vascular stenosis in hemodialysis. Multiple factors have limited the efficacy of DCB. Previous studies on the related factors of hemodialysis access stenosis showed that Dyslipidemia was significantly related to the short initial patency rate, and Dyslipidemia was an important predictor of secondary patency loss. Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors are a new type of lipid-lowering drug that can prevent vascular calcification. Previous studies have shown that PCSK9 inhibitors have good lipid-lowering effects in both MHD patients and nondialysis patients, and the use of PSK9 inhibitors at the same dose as nondialysis patients is safe in MHD patients. There are currently few studies on the use of paclitaxel-releasing balloon dilation combined with PCSK9 inhibitors to improve autologous internal fistula. Therefore, the investigators applied a prospective, randomized, and controlled study method to preliminarily explore the effect of paclitaxel releasing balloon combined with PCSK9 inhibitor on improving the postoperative patency rate of AVF and the safety of the combined application.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06034691
Study type Interventional
Source RenJi Hospital
Contact
Status Recruiting
Phase N/A
Start date September 10, 2023
Completion date October 1, 2024

See also
  Status Clinical Trial Phase
Completed NCT03952819 - The Effects of Hemodialysis on Serum Sclerostin Levels
Active, not recruiting NCT04054128 - Bicarbonate vs Heparin Catheter Lock in Chronic Hemodialysis Patients Phase 4
Completed NCT03627884 - Outcomes of the Use of Sodium Bicarbonate (8.4%) Solution as a Catheter Lock Solution to Prevent Hemodialysis Catheter Loss Due to Lumen Clot Formation Phase 4
Recruiting NCT06001827 - SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study N/A
Recruiting NCT04285073 - Prospective, Multicenter, Non-randomized, Single Arm Clinical Trial to Evaluate the Safety and Efficacy of e-PTFE Grafts Inner Surface-treated With Paclitaxel as an Access for Hemodialysis in Patients With End-stage Renal Disease. N/A
Recruiting NCT05906550 - Flow Dysfunction of Hemodialysis Vascular Access N/A
Not yet recruiting NCT04098159 - Role of Regular Surveillance on Maintenance of Patency of an Arteriovenous Access N/A
Terminated NCT05228132 - The Pristine Post-Market Study N/A
Recruiting NCT03365089 - Collateral Ligation in Failing Fistulas N/A
Recruiting NCT04489849 - Apixaban for Prevention of Post-angioplasty Thrombosis of Hemodialysis Vascular Access Phase 4
Recruiting NCT03140345 - Integrative HD Vascular Access Assessment N/A
Enrolling by invitation NCT04381754 - Use of Implanting the Biotronik Passeo-18 Lux Drug Coated Balloon to Treat Failing Haemodialysis Arteriovenous Fistulas and Grafts.
Completed NCT03988270 - Prefistula Forearm Exercise in Pts Requiring Chronic HD Therapy N/A
Recruiting NCT04502160 - The Northern Ireland Haemodialysis Vascular Access Database
Active, not recruiting NCT05418816 - SelfWrap-Assisted Arteriovenous Fistulas N/A
Completed NCT04263116 - Balloon-Assisted Maturation of Autogenous Arteriovenous Fistulae N/A
Completed NCT05081648 - Must Cannulation Technique of Vascular Access in Patients Undergoing Haemodialysis: Contributions for a Safe Nursing Intervention N/A
Not yet recruiting NCT05096416 - Three-dimensional (3D) Printed Hemodialysis Vascular Model N/A
Recruiting NCT04692636 - BP Variability on the Outcomes of Hemodialysis Vascular Access
Completed NCT04446546 - Results of Cold Stored Allografts in Vascular Access